Share this
Legal 500 US 2019 Highlights Cooley
August 29, 2019
Gossamer Bio – $317 Million IPO
One of the largest healthcare IPOs of the last 20 years • February 21, 2019
Taiwan Liposome Company Completes US IPO
January 3, 2019
The Legal 500 2018 Recognizes Cooley
September 7, 2018
Best Lawyers 2019 – Cooley
August 16, 2018
ASLAN Pharmaceuticals – $42 Million IPO
First Taipei Exchange-listed company to go public in US • June 8, 2018
DocuSign – $723.7 Million IPO
Second largest software IPO in last decade • May 1, 2018
Uber Closes SoftBank Investment
February 12, 2018
Personal Shopping Service Stitch Fix Raises $120 Million in IPO
November 21, 2017
Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering
September 22, 2017
Best Lawyers 2018 – Cooley
August 16, 2017
Redfin – $159 Million IPO
August 3, 2017
Cooley Advises on Series of Life Sciences IPOs
Zymeworks, Verona, UroGen and Biohaven IPOs highlight core strengths across the sector • May 30, 2017
Audentes – $86 Million Shelf-Takedown Offering
April 27, 2017
Yext – $133 Million IPO
April 25, 2017
Tocagen – $98 Million IPO
April 20, 2017
Alteryx – $145 Million IPO
April 12, 2017
Calithera Biosciences – $80 Million Shelf-Takedown Offering
April 7, 2017
Vital Therapies – $40 Million Follow-on Offering
March 29, 2017
Anthera – $15 Million Shelf-Takedown Offering
March 22, 2017
Kite Pharma – $410 Million Shelf‑Takedown Offering
Dermira – $194 Million Shelf-Takedown
March 10, 2017
Global Blood Therapeutics – $144 Million Shelf‑Takedown
March 8, 2017
Rigel – $46 Million Shelf-Takedown
February 17, 2017
NantHealth – $107 Million Notes Offering
January 11, 2017
Xencor – $127 Million Shelf-Takedown
December 8, 2016
Invitae – $51 Million Follow-On
November 30, 2016
Flexion – $70 Million Shelf-Takedown
November 29, 2016
HealthEquity – $90 Million Follow-On
November 4, 2016
Ascendis Pharma – $136 Million Follow-On
November 3, 2016
Cidara – $28 Million Follow-On Offering
October 21, 2016
Apptio – $110 Million IPO
October 10, 2016
BioMarin – $720 Million Follow-On
September 19, 2016
Xenon Pharmaceuticals – $34.5 Million Follow-On
September 16, 2016
Uber to Buy Self-Driving Truck Startup Otto
September 7, 2016
Advaxis – $30 Million Registered Direct Offering
August 30, 2016
Acadia – $230 Million Follow-On
August 25, 2016
Medivation Agrees to Sell to Pfizer for $14 Billion
August 23, 2016
Gemphire Therapeutics – $30 Million IPO
August 22, 2016
Inotek Pharmaceuticals – $50 Million Follow-On
August 18, 2016
Best Lawyers 2017 – Cooley
August 15, 2016
Audentes Therapeutics – $85 Million IPO
July 29, 2016
Syros IPO – $58 Million
July 26, 2016
Minerva – $58 Million Follow-On Offering
July 7, 2016
Flexion – $77 Million Follow-On Offering
Dermira – $145 Million Follow-On Offering
June 23, 2016
Clearside IPO – $50 Million
June 21, 2016
NantHealth IPO – $97 Million
June 13, 2016
Senseonics Holdings, Inc. – $49 Million IPO
April 13, 2016
Voyager Therapeutics – IPO
November 19, 2015
Strongbridge Biopharma – IPO
October 27, 2015
Cooley Advises on Series of SaaS Sales to Microsoft
September 22, 2015
Best Lawyers 2016 – Cooley
August 18, 2015
NantKwest – $238 Million IPO
August 14, 2015
ProNAi – $158 Million IPO
August 7, 2015
Ooma Prices $65 Million IPO
July 31, 2015
Catabasis Completes IPO
July 20, 2015
NVIDIA Secures $380 Million Synthetic Lease for New Headquarters
July 1, 2015
MINDBODY Completes $100 Million IPO
June 26, 2015
HTG Completes its Initial Public Offering
May 20, 2015
Apigee Completes Its Initial Public Offering
May 11, 2015
KemPharm Completes its Initial Public Offering
April 28, 2015
Cidara Completes its Initial Public Offering
April 24, 2015
Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering
March 30, 2015
Rovi Completes $345 Million Convertible Note Offering
March 26, 2015
Cooley Clients Featured in Daily Journal's "Top Deals of 2014"
March 25, 2015
Invitae Completes $117 Million Initial Public Offering
February 25, 2015
Inotek Pharmaceuticals – $40 Million IPO
February 23, 2015
TRACON Pharmaceuticals Completes Initial Public Offering
February 13, 2015
Bellicum Completes $160 Million Initial Public Offering
Ascendis Pharma Closes $124 Million Initial Public Offering
New Relic Completes $132 Million Initial Public Offering
December 19, 2014
Ionis Pharmaceuticals Completes Rule 144A Offering of $500 Million of Convertible Senior Notes
December 2, 2014
Xenon Pharmaceuticals Completes its Initial Public Offering
November 21, 2014
Atara Completes its Initial Public Offering
November 6, 2014
Vascular Biogenics Prices its Initial Public Offering
November 5, 2014
Dermira Prices its Initial Public Offering
October 27, 2014
Cooley Advises Jazz Pharmaceuticals plc on Rule 144A Offering of $575 Million of Exchangeable Senior Notes
September 25, 2014
Cooley Advises Underwriters on T2 Biosystems IPO
August 22, 2014
Cooley Advises Underwriters on Otonomy IPO
August 19, 2014
Best Lawyers 2015 – Cooley
August 18, 2014
Cooley Advises Underwriters on HealthEquity's $146.5 Million IPO
August 11, 2014
Cooley Advises Underwriters on Immune Design IPO
Cooley Advises Underwriters on Minerva Neurosciences IPO
July 11, 2014
Cooley Advises Kite Pharma on $146 Million Initial Public Offering
July 1, 2014
Cooley Advises Underwriters on Zendesk's $115 Million Initial Public Offering
May 23, 2014
Cooley Advises Alder Biopharmaceuticals on Initial Public Offering
May 14, 2014
Cooley Advises Underwriters on TriVascular IPO
April 23, 2014
Cooley Advises Underwriters on Vital Therapies Initial Public Offering
Cooley Advises Underwriters on Aerohive Networks IPO
April 4, 2014
Cooley Advises TriNet on its $276 Million Initial Public Offering
March 31, 2014
Cooley Advises Underwriters on Castlight Health's $204 Million IPO
March 18, 2014
Cooley Advises Underwriters on Amedica IPO
March 4, 2014
Cooley Advises Auspex on its Initial Public Offering
February 24, 2014
Cooley Advises Underwriters on Egalet Corporation IPO
February 21, 2014
Cooley Advises Underwriters on Eleven Biotherapeutics IPO
February 14, 2014
Cooley Advises Trevena on its Initial Public Offering
February 11, 2014
Cooley Advises on First US IPO of 2014 for GlycoMimetics
January 23, 2014
Cooley Advises Underwriters on Five Prime Therapeutics IPO
September 23, 2013
Cooley Advises Underwriters on LinkedIn's $1.25 Billion Follow-On Offering
September 10, 2013
Numerous Cooley Attorneys Recognized in Best Lawyers 2014
August 15, 2013
Cooley Advises Underwriters on Onconova Therapeutics IPO
August 8, 2013
Cooley Practices and Attorneys Recognized in 2013 Legal 500 Client Guide
June 24, 2013
Cooley Advises Underwriters on Epizyme, Inc. Initial Public Offering
June 14, 2013
Cooley Advises Portola Pharmaceuticals on its $140 Million IPO
May 29, 2013
Cooley Advises Ambit on its Initial Public Offering
May 21, 2013
Cooley Advises Underwriters on Receptos, Inc. Initial Public Offering
May 20, 2013
Cooley Advises Underwriters on Cyan, Inc. Initial Public Offering
Cooley Advises Insys Therapeutics on its IPO
May 9, 2013
Jawbone Acquisition of Body Media
April 30, 2013
95 Cooley Attorneys Recognized in Best Lawyers
September 19, 2012
Cooley Advises JSM Acquisition in $800 Million Sale of San Diego Padres
August 29, 2012
Peet's Coffee & Tea $1 Billion Sale
July 23, 2012
The JOBS Act Relaxes Requirements For Going Public And Being Public
Cooley Alert • April 5, 2012